• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

每一位被作为甲状腺乳头状癌患者进行随访的患者真的是这种病吗？

Is Every Patient Followed up as a Papillary Thyroid Cancer Patient Really That?

作者信息

Abdulrezzak Ummuhan, Tutus Ahmet, Kula Mustafa, Oztürk Figen, Soyuer Işın

机构信息

Erciyes University School of Medicine, Department of Nuclear Medicine, Kayseri, Turkey.

出版信息

Mol Imaging Radionucl Ther. 2012 Apr;21(1):38-41. doi: 10.4274/Mirt.022866. Epub 2012 Apr 1.

DOI:10.4274/Mirt.022866
PMID:23487501
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3590961/
Abstract

UNLABELLED

We report the case of a 64-year-old man followed up for two years as suffering from differentiated thyroid cancer (DTC). In the patient's follow up, despite thyroglobulin level and I-131 whole body scan results being normal, metastases were identified at the 4th thoracic vertebra corpus by MR. Histopathological findings were carcinoma metastases. F-18 FDG PET/CT showed increased metabolic activity in the right renal mass, bilaterally in the surrenal gland, multiple lymph nodes in the thoracic and abdominal para-aortic region and in multiple vertebral and pelvic bones. An excisional biopsy of the right renal mass was reported as renal cell carcinoma. Immunohistochemical staining performed retrospectively to the first thyroid preparation showed renal cell carcinoma metastases. Consequently, any patient who presents with a thyroid nodule can also be considered as possibly suffering from metastatic disease. F-18 FDG PET/CT can provide valuable information in finding the primary focus and metastases.

CONFLICT OF INTEREST

None declared.

摘要

未标注

我们报告了一例64岁男性患者，因分化型甲状腺癌（DTC）接受了两年随访。在患者的随访过程中，尽管甲状腺球蛋白水平和碘-131全身扫描结果正常，但磁共振成像（MR）在第4胸椎椎体发现了转移灶。组织病理学检查结果为癌转移。氟-18氟代脱氧葡萄糖正电子发射断层显像/X线计算机体层成像（F-18 FDG PET/CT）显示右肾肿块、双侧肾上腺、胸腹部主动脉旁区域的多个淋巴结以及多个椎骨和骨盆骨代谢活性增加。右肾肿块切除活检报告为肾细胞癌。对首次甲状腺标本进行的回顾性免疫组化染色显示为肾细胞癌转移。因此，任何出现甲状腺结节的患者也应被视为可能患有转移性疾病。F-18 FDG PET/CT在寻找原发灶和转移灶方面可提供有价值的信息。

利益冲突

未声明。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c17/3590961/cc5dfa871412/MIRT-21-38-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c17/3590961/b349d44d9006/MIRT-21-38-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c17/3590961/4a84237327a3/MIRT-21-38-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c17/3590961/cc5dfa871412/MIRT-21-38-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c17/3590961/b349d44d9006/MIRT-21-38-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c17/3590961/4a84237327a3/MIRT-21-38-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c17/3590961/cc5dfa871412/MIRT-21-38-g3.jpg

相似文献

1
Is Every Patient Followed up as a Papillary Thyroid Cancer Patient Really That?每一位被作为甲状腺乳头状癌患者进行随访的患者真的是这种病吗？
Mol Imaging Radionucl Ther. 2012 Apr;21(1):38-41. doi: 10.4274/Mirt.022866. Epub 2012 Apr 1.
2
Metabolic and functional imaging employment in the differentiation of brown tumors from bone metastases in a case of primary papillary thyroid cancer and parathyroid adenoma: case report.代谢和功能成像在原发性甲状腺乳头状癌和甲状旁腺腺瘤伴棕色瘤骨转移中的应用：病例报告。
J Egypt Natl Canc Inst. 2021 Oct 18;33(1):30. doi: 10.1186/s43046-021-00089-x.
3
Risk factors and stratification for recurrence of patients with differentiated thyroid cancer, elevated thyroglobulin and negative I-131 whole-body scan, by restaging F-FDG PET/CT.通过重新分期的F-FDG PET/CT评估分化型甲状腺癌、甲状腺球蛋白升高且I-131全身扫描阴性患者复发的危险因素及分层
Hell J Nucl Med. 2016 Sep-Dec;19(3):208-217. doi: 10.1967/s002449910402. Epub 2016 Nov 8.
4
Papillary thyroid carcinoma presenting as a primary renal tumor with multiple pulmonary and bone metastases: a case report.表现为原发性肾肿瘤伴多发肺和骨转移的甲状腺乳头状癌：一例报告
J Med Case Rep. 2019 Apr 20;13(1):95. doi: 10.1186/s13256-019-2025-8.
5
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
6
Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.18F-FDG PET在131I全身扫描阴性的乳头状甲状腺癌中的价值
J Nucl Med. 1999 Jun;40(6):986-92.
7
Polysplenia Syndrome With Splenic and Skeletal Muscle Metastases From Thyroid Carcinoma Evaluated by FDG PET/CT: Case Report and Literature Review: A Care-Compliant Article.通过氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描（FDG PET/CT）评估的伴有甲状腺癌脾脏和骨骼肌转移的多脾综合征：病例报告及文献综述：一篇符合规范的文章
Medicine (Baltimore). 2016 Jan;95(4):e2532. doi: 10.1097/MD.0000000000002532.
8
PROGNOSTIC VALUE OF LYMPH NODE UPTAKE ON PRETREATMENT F-18 FDG PET/CT IN PATIENTS WITH N1B PAPILLARY THYROID CARCINOMA.N1b 期滤泡状甲状腺癌患者术前 F-18 FDG PET/CT 淋巴结摄取的预后价值。
Endocr Pract. 2019 Aug;25(8):787-793. doi: 10.4158/EP-2018-0607. Epub 2019 Apr 23.
9
[F-18-fluordeoxyglucose positron emission tomography on patients with differentiated thyroid cancer who present elevated human serum thyroglobulin levels and negative I-131 whole body scan].[对血清甲状腺球蛋白水平升高且碘-131全身扫描阴性的分化型甲状腺癌患者进行氟-18-氟脱氧葡萄糖正电子发射断层扫描]
Rev Esp Med Nucl. 2005 Jan-Feb;24(1):5-13. doi: 10.1157/13070351.
10
Iodine-131 SPET/CT and 18F-FDG PET/CT for the identification and localization of mediastinal lymph node metastases from differentiated thyroid carcinoma.碘-131单光子发射计算机断层扫描/计算机断层扫描（SPET/CT）和18F-氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描（18F-FDG PET/CT）用于鉴别和定位分化型甲状腺癌的纵隔淋巴结转移灶。
Hell J Nucl Med. 2013 Sep-Dec;16(3):199-203.

本文引用的文献

1
Thyroid cancer survival in the United States: observational data from 1973 to 2005.美国甲状腺癌患者的生存率：1973年至2005年的观察数据。
Arch Otolaryngol Head Neck Surg. 2010 May;136(5):440-4. doi: 10.1001/archoto.2010.55.
2
Thyroid metastasis of clear cell renal carcinoma: Report of a case.透明细胞肾细胞癌的甲状腺转移：一例报告。
Diagn Cytopathol. 2009 Oct;37(10):759-62. doi: 10.1002/dc.21117.
3
Value of 18F-FDG-PET/PET-CT in differentiated thyroid carcinoma with radioiodine-negative whole-body scan: a meta-analysis.18F-FDG-PET/PET-CT在放射性碘全身扫描阴性的分化型甲状腺癌中的价值：一项荟萃分析。
Nucl Med Commun. 2009 Aug;30(8):639-50. doi: 10.1097/MNM.0b013e32832dcfa7.
4
Metastatic renal cell carcinoma to the thyroid gland.甲状腺转移性肾细胞癌。
Endocr Pract. 2008 Nov;14(8):1040-6. doi: 10.4158/EP.14.8.1040.
5
Changing patterns in the incidence and survival of thyroid cancer with follicular phenotype--papillary, follicular, and anaplastic: a morphological and epidemiological study.具有滤泡样表型的甲状腺癌（乳头状癌、滤泡状癌和未分化癌）发病率及生存率的变化模式：一项形态学与流行病学研究
Endocr Pathol. 2007 Spring;18(1):1-7. doi: 10.1007/s12022-007-0002-z.
6
Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation.全甲状腺切除及（131）I 消融术后分化型甲状腺癌且甲状腺球蛋白升高患者的氟脱氧葡萄糖 PET/CT 检查
Q J Nucl Med Mol Imaging. 2008 Mar;52(1):2-8.
7
Metastases to the thyroid gland: the Royal Marsden experience.甲状腺转移：皇家马斯登医院的经验
Eur J Surg Oncol. 2004 Aug;30(6):583-8. doi: 10.1016/j.ejso.2004.03.012.
8
A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma.一份关于血清甲状腺球蛋白作为低风险甲状腺乳头状癌患者监测方法作用的共识报告。
J Clin Endocrinol Metab. 2003 Apr;88(4):1433-41. doi: 10.1210/jc.2002-021702.
9
[Thyroid metastasis from renal carcinoma. Clinical case].[肾癌的甲状腺转移。临床病例]
Chir Ital. 2002 Nov-Dec;54(6):861-7.
10
Value of preoperative diagnostic modalities in patients with recurrent thyroid carcinoma.术前诊断方法在复发性甲状腺癌患者中的价值。
Surgery. 2000 Dec;128(6):1067-74. doi: 10.1067/msy.2000.110771.